Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

Figure 14

Motif analysis for LRGs. (a) These transcription factors were enriched by cumulative recovery curves. The normalized enrichment score of four hub motifs, cisbp__M5876 (b), cisbp__M1613 (c), and cisbp__M5411 (d).

(a)

(b)

(c)

(d)